Table 2.
Antifungal susceptibility profile of Candida species isolated from the environment and staff of a Brazilian Tertiary Hospital.
| Candida species (number of isolates) | Antifungal agent | Classification (% of isolates) |
||
|---|---|---|---|---|
| S | SDD | R | ||
| C. glabrata (8) | Fluconazole | 25.0 | 25.0 | 50.0 |
| Amphotericin B | 100.0 | – | – | |
| Miconazole | 25.0 | 62.5 | 12.5 | |
| Itraconazole | 62.5 | 37.5 | – | |
| Ketoconazole | 100.0 | – | – | |
| Nystatin | 100.0 | – | – | |
| C. albicans (6) | Fluconazole | 66.6 | 33.3 | – |
| Amphotericin B | 100.0 | – | – | |
| Miconazole | 50.0 | 50.0 | – | |
| Itraconazole | 33.3 | 66.6 | – | |
| Ketoconazole | 100.0 | – | – | |
| Nystatin | 100.0 | – | – | |
| C. parapsilosis (6) | Fluconazole | 83.3 | 16.7 | – |
| Amphotericin B | 100.0 | – | – | |
| Miconazole | 16.7 | 50.0 | 33.3 | |
| Itraconazole | 16.7 | 50.0 | 33.3 | |
| Ketoconazole | 100.0 | – | – | |
| Nystatin | 100.0 | – | – | |
| C. tropicalis (6) | Fluconazole | 100.0 | – | – |
| Amphotericin B | 100.0 | – | – | |
| Miconazole | 66.6 | 16.7 | 16.7 | |
| Itraconazole | 16.7 | 50.0 | 33.3 | |
| Ketoconazole | 83.3 | 16.7 | – | |
| Nystatin | 100.0 | – | – | |
| C. krusei (4) | Fluconazole | – | – | 100.0 |
| Amphotericin B | 75.0 | – | 25.0 | |
| Miconazole | – | 50.0 | 50.0 | |
| Itraconazole | – | 75.0 | 25.0 | |
| Ketoconazole | 100.0 | – | – | |
| Nystatin | 100.0 | – | – | |
S, susceptible; SDD, dose-dependent susceptible; R, resistant.